On Friday, May 17, 2019, immuno-oncology and policy experts convened in Washington, D.C., for a one-day summit to discuss future policy direction related to patient access and treatment with immunotherapies, as well as to collaboratively identify potential solutions and best practices. The conversation explored critical issues facing the immuno-oncology community and helped to identify key priorities and next steps to accelerate the advancement of immuno-oncology in the community setting. The summit discussion was framed around three key areas: telehealth, care coordination and workforce, and CAR-T therapy.